1617138-3

Due to market price fluctuations, if you need to purchase or consult the price. You can contact us or emial to us:   sales@allicdata.com

The 1617138-3 application is geared towards the detection and removal of malignant cancer cells in humans. It is a device which operates primarily through the use of high intensity focused ultrasound (HIFU). HIFU is a technique which uses focused, high power acoustic energy to precisely target and destroy diseased and injured tissues. In this particular application, the HIFU energy is able to penetrate tissue to the deepest layers and effectively target cancer cells. HIFU is an advantageous tool for detection and treatment of cancer, due to its efficiency in targeting and destroying smaller, deeper tumors.

The working principle of 1617138-3 system depends highly on the relationship between acoustic signals and tissue properties. Ultrasound is generated using an array of sources, and these signals are transmitted through the tissue to the desired target. In the target region, acoustic energy is localized due to the attenuation, which implies that the intensity of the signal emitted is affected by the tissue type. This tissue-dependent attenuation allows the system to detect specific targets with accuracy. As a result, the system is able to focus on the desired regions of the human body and efficiently remove tumors without causing any harm to healthy tissues.

The working of 1617138-3 system begins by imaging the tissue and determining the location of the targeted tissue. Through the use of computer aided diagnosis (CAD), the system is able to accurately detect the areas requiring treatment. Once the location of the targeted tissue is determined, the energy pulses of the HIFU are emitted towards the tissue to be treated. Due to the method of localized energy delivery used by HIFU, the pulse is able to penetrate the tissue and efficiently destroy the tumors without affecting the surrounding healthy tissue.

The 1617138-3 application is an innovative technology that combines HIFU and CAD, and has shown to be effective in targeting and removing malignant tumors. It is beneficial for numerous types of larger and deeper tumors in various locations, as it allows for a targeted, precise, and minimally invasive treatment. HIFU has also been demonstrated to have a low rate of complications, exhibit long-term tissue responses, and has minimally altered tissue pharmacokinetics, making it an appealing alternative to traditional treatments such as surgical resection or radiation.

In conclusion, the 1617138-3 application field and working principle makes it one of the most effective and efficient technologies for the detection and removal of malignant tumors. Its combination of HIFU and CAD makes it an economically viable option when compared to traditional cancer treatments. Furthermore, due to its localized nature, it is minimally invasive and possesses a low rate of complications. The technology is one which is here to stay for the betterment and increased quality of life of humans.

The specific data is subject to PDF, and the above content is for reference